Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 79.20
+0.40 (0.51%)
May 7, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 15.67 billion as of May 7, 2026.
Market Cap
15.67B
Enterprise Value
14.26B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
79.20
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has increased from 12.97B to 15.67B, an increase of 20.79%. That is a compound annual growth rate of 27.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 15.75B | 55.29% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 24.93B |
| Keymed Biosciences | 22.26B |
| TransThera Sciences (Nanjing) | 20.85B |
| Zai Lab | 18.96B |
| Ascletis Pharma | 17.48B |
| Ascentage Pharma Group International | 16.44B |
| CStone Pharmaceuticals | 14.85B |
| Everest Medicines | 12.14B |